Cancer Microbes and Morgellons

[tcmgpt13]

I am not sure whether to laugh or cry about this article, but I think it is a very interesting article in that Dr. Alan Cantwell discusses his findings of cancer causing microbes which medicine has ignored studying for over a century. He also touches in this interview upon the fact that this sort of bacteria may also be found in AIDS and scloderma patients. The intriguing thing about Dr. Cantwell is his background. He is a dermatologist who worked for Kaiser Permanente from 1965-1994. In this interview he touches on reasons why this organization will most likely not be the organization which discovers the morgellons parasite (this is my indirect conclusion from what he says about Kaiser Permanente and his research there on cancer microbes). If they would bring this man out of retirement we might have a chance to find out what is causing morgellons symptoms, but there seems to be no possibility of that since when employed by Kaiser he was finding cancer microbes in entirely too many chronic illnesses to suit those in the know:

http://bacteriality.com/2007/09/11/cantwell/

“6. What’s going on? Why aren’t doctors and researchers taking the idea that bacteria cause cancer seriously?

As I see it, the identification of simple-to-see cancer microbes would cause havoc in the scientific world and in the cancer treatment industry. It would be the biggest embarrassment to befall modern medicine. Can you imagine the furor resurrecting Russell’s “cancer parasite” — the “parasite” that was thrown out of medical science a century ago?

It is rare to find a scientist interested in “cancer microbes.” Most physicians are repelled by the idea that bacteria cause cancer. How do you prod scientists to become interested? I’m still not sure.”

“11. What concerns did Kaiser Permanente have about your research?

A problem with my research was that over a period of years I was finding acid-fast bacteria in patients with a wide array of different illnesses. Some skeptics would say “OK, maybe I can accept that you found bacteria in scleroderma, but come on, in all these diseases?” After several years of productive cancer microbe research, the research committee insisted I be interviewed by a statistician. The committee was concerned because I was discovering bacteria in too many diseases. The statistician insisted that I attempt a statistical study of these bacteria with suitable “controls.” I explained that previous researchers had already determined that all human beings harbor such bacteria, and that these bacteria needed further study as pathogens. It might be impossible to find “negative” controls. At that point I thought, “I’m doomed.” There was no way I could do a statistical analysis of my observations. My research was terminated.”

Since I have used three different herbal cancer salves which will not work on normal skin and have been able to draw out these parasites and associated infections, I found Cantwell views on this subject illuminating.

[Jo]

Hey TCM,

Thanks, loved your post. Mind boggling

Lack of negative controls. He must have been p**sed.

I never thought about common pathogens - being so common, that they'd prevent the construction of controlled trials. Barriers sound more political, than scientific.

What kind of crazy world are we living in?

Jo xxx

[Kritters]

What kind of crazy world are we living in, Jo????

A PARASITIC WORLD!!! These things have been here long before humans were a mere twinkling in their eyes (only kidding everybody)

They are so far superior than mammals in survival. If we understood their language and our hearing was acute enough to hear it,

naaaaah....things wouldn't be better. The CDC would ignore them too.

Here's how much I think scientists have missed the mark....I am beginning to doubt that their classifications and species of fungi, viruses, bacteria, etc. are accurate or are understood at all. That, my friend is really scary. When a group of non-scientists get together (us) and through personal research find out what we can put together and solve the mystery of a disease, when they have been sitting around with their heads up their asses and ignoring all information prior to what, 1980 which could lead to cures, it makes me wonder what this millenium will really bring and why it's taking people like us to make a difference.



xoxoKritts

[Niels]

The "cancer microbe" is called chlamydia pneumoniae, also potentially implicated
per Dr. Harvey in Morgellons. Here's a patent on using antibiotics to cure cancer
and other autoimmune diseases
http://www.freshpatents.com/Diagnosi...0060052278.php

Title: Diagnosis and treatment of human dormancy-related sequellae
Abstract: New methods for diagnosis and treatment of human dormancy syndrome-related sequellae are provided. Human dormancy syndrome (HDS) is characterized by elevated serum ratio of rT3/fT3 compared to a population of normal subjects. HDS includes fibromyalgia, chronic fatigue, cancer, autoimmune disease, obesity and related dormancy conditions. Dormancy and HDS-related sequellae are imposed on humans by infection with lipopolysaccharide (LPS; or endotoxin)-producing organisms, especially those that are intracellular and those that create antigens that stimulate the TLR pathways. In such instances, the elimination or neutralization of the LPS signal along with the infectious source is required to impact the sequellae of HDS. Treatment includes use of novel and non-obvious doses of antibiotics, optionally including agents that decrease the adverse effects of endotoxin. (end of abstract)

CLAIM OF PRIORITY

[0001] This application is a Continuation-In-Part of U.S. Ser. No. 10/444,845, filed May 23, 2003, titled "Diagnosis and Treatment of Human Dormancy Syndrome," Inventor, Michael Powell, (Attorney Docket No: POWL 1000 US1) which claimed priority under 35 U.S.C. .sctn.119 to U.S. Provisional Patent Application Ser. No. 60/382,913, filed May 23, 2002 and to U.S. Provisional Patent Application Ser. No. 60/383,271, filed May 24, 2002, titled Diagnosis and Treatment of Human Hibernation Syndrome," Inventor, Michael Powell. Each of the aforementioned applications is incorporated herein fully by reference.

FIELD OF THE INVENTION

[0002] This invention relates to methods for diagnosing and treating sequellae related to human dormancy syndrome, including cancer and autoimmune disease. In particular, this invention relates to treating cancer and/or autoimmune diseases using combination therapy using antibiotics.

BACKGROUND

[0003] Human Dormancy Syndrome (HDS) is a newly recognized syndrome involving an elevated reverse triiodothyronine ("rT3") to free triiodothyronine ("fT3") ratio and one or more symptoms (see U.S. patent application Ser. No. 10/444,845, incorporated by reference). Diagnosis of HDS was enabled by the recognition that the rT3/fT3 ratio of prior studies was inaccurate, in that subjects considered "normal," in fact, had a disorder as described in the above patent application, the recognition of a lower level of true "normal" subjects, diagnosis of HDS has led to improved treatment.

[0004] Cancers are among the most difficult diseases to treat. Cancers are known to be multifactoral, involving genetic predisposition, uncontrollable environmental factors and controllable factors, such as smoking, ingestion of carcinogens etc. Morbidity and mortality exact a large human and economic cost from our society. Current therapies for cancer include chemotherapy using cytotoxic agents, antibodies against cancer cells, and/or radiation therapy, among other treatments.

[0005] Early diagnosis of cancer has been one of the more effective determinants of successful anti-cancer therapy. Many methods are used to detect cancer, including histological examination, detection of cancer markers in serum and other bodily fluids, physical examination, patient history, magnetic resonance imaging, positron emission tomography, x-ray, ultrasound and other methods.

[0006] However, mechanisms of cancer formation and factors that contribute to cancer growth are not well known. There is general acceptance that certain cancers are associated with mutations in genes (oncogenes) that are present in human cells. Other types of cancers are known to be associated with certain viral infections.

[0007] Likewise, autoimmune diseases have a complex etiology, and in many cases, are poorly understood and poorly treated. Thus, predicting the outcome of autoimmune disorders is uncertain, and can lead to ineffective treatments and/or lost time, during which an autoimmune disorder can worsen.

[0008] Therefore, there is a great desire to understand the etiology of complex diseases, and development of effective treatments is a major public health concern.

SUMMARY OF THE INVENTION

[0009] Thus, one object of this invention is the diagnosis of human dormancy syndrome as well as the tumorogenic, immunologic and infectious consequences that frequently follow dormancy related physiologic changes.

[0010] Another object of this invention is to provide effective therapy for conditions related to human dormancy syndrome, and this includes, but is not limited to, the treatment of organisms that exploit the physiologic and immunologic conditions of human dormancy syndrome.

[0011] To address these and other objects, embodiments of this invention include the identification that several autoimmune disorders and tumors have striking similarities to HDS. In turn, HDS has similarities to certain fetal conditions. Thus, in certain embodiments, treatment of autoimmune disorders or tumors can be carried out using combination therapy using antibiotics to decrease bacterial infection, which is associated with HDS, autoimmune disorders and certain tumors.

[0012] In certain of these embodiments, new regimens for using antibiotics have unexpectedly desirable therapeutic effects, including remission or disappearance of tumors, increased life span, and other beneficial effects. Traditional antibiotic treatment is initiated, and generally, doses of antibiotics are limited to those that provide a desirable killing of the microbes, without causing adverse changes such as the Jarisch-Herxheimer (JH) reaction, which represents release of bacterial products at a high rate and the consequent adverse reactions to those products, including endotoxin. Additionally, when traditional antibiotic therapy has produced the desired bacteriocidal effects and an endotoxin response (JH reaction) has abated, the antibiotic is either continued at that dose, is tapered off or is stopped.

[0013] In contrast, in embodiments of this invention, once an endotoxin response has been observed and has abated to a tolerable level, the dose of the antibiotic is increased rather than decreased. This counter-intuitive step permits the antibiotic to enter cells harboring the infective agent and can kill the agent within the cell, and therefore initiate cell death. Certain cancers and autoimmune disorders are associated with intracellular infections. Thus, by use of the counterintuitive step of increasing the antibiotic dose at a time in which the symptoms of systemic infection are abating, one can effectively treat autoimmune disorders or cancers.

[0014] What is currently recognized as stress-influenced, noninfectious autoimmune disease is a process related to human dormancy syndrome with secondary exacerbation by lipopolysaccharide ("LPS") (or other superantigen) producing organisms, especially Chlamydia pneumoniae (Cpn), Mycoplasma pneumoniae (Mpn), Helicobacter pylori (Hpi), and/or fungal infections. Diagnosis and treatment of autoimmune disease can benefit from testing and treatment of human dormancy syndrome, cancer, Cpn, Mpn and fungal infections. Measurement of the rT3/fT3 ratio, nitric oxide levels, DHEA-S, free testosterone, estriol, estradiol levels or other variables denoted in Table 1 are helpful for the purposes of diagnosing human dormancy syndrome, and numerous clinical and biochemical tests, including diagnostic markers can be measured (see below) and can indicate presence of cancers associated with infections by Cpn, Mpn, Hpi and fungi. Measurement of sympathetic nervous system hyperactivity using electronic devices designed to measure "stress", such as biofeedback machines, could also be beneficial for diagnostic purposes.

Treatment of Cancer

[0015] Embodiments of this invention are based on the surprising finding that in many types of cancer, opportunistic infections with Chlamydia (including Chlamydia pneumoniae ("Cpn")) are present. Embodiments of this invention are also based upon the surprising finding that many types of cancer are also associated with Cpn are also associated with elevated rT3/fT3 ratio, and thus are related to HDS.

[0016] Additional embodiments of this invention are based on the unexpected finding that Chlamydial infections are often associated with HDS. These observations have led to the surprising results that many types of cancer can be effectively treated using anti-Chlamydial agents along with other, conventional antitumor therapies. In other embodiments, co-therapy using anti-Clamydial agents and treatment for HDS can decrease progression of cancer, can decrease symptoms and in some cases, can eradicate all trace of cancer from subjects suffering from many types of cancers.

[0017] Thus, in certain embodiments, cancer therapy can be improved by treatment with antibiotics. In particular, in certain embodiments, flagyl can be used. In prior methods to treat bacterial-associated disorders, the dose of antibiotic has been limited to avoid the undesirable effects of rapid bacterial killing (Jarisch Herxsheimer reaction). However, we unexpectedly found that by selecting patients in whom the adverse reaction has been managed through decreasing endotoxin levels, further increases in doses of antibiotics can be administered that can induce killing of tumor cells. These results have been shown in a series of patients with differing types of tumors.

[0018] LPS has been found to stimulate cancer cell growth and impair immune function therefore concomitant treatment with endotoxin (LPS) binding agents, plasmophoresis, dephosphorylating agents or other LPS neutralizing agents are an expected adjunct to the treatment of LPS induced HDS. Other measures include but are not limited to the use of agents that reduce the activity of NF kappa B, kinin, angiotensin (i.e.-ACE inhibitors or ARB's), reduce the activity of COX-2 and PGE2 (i.e.-NSAIDs or omega 3 oils), increase junB activity or lowers HSP70 activity (i.e. ascorbic acid), or increase oxytocin or nitric oxide levels (i.e.-oxytocin, nitroglycerine, Viagra). Treatment with LPS neutralizing agents should be implemented prior to the onset of cancer, bacterial or fungal cell apoptosis inducing therapies.

... (see link to read more) ...

[tcmgpt13]

I believe there may be more than one bacteria involved in causing cancer, and that this may be why Cantwell calls it a cancer microbe:

http://en.wikipedia.org/wiki/Cancer_bacteria

"Known to cause cancer

Helicobacter pylori colonizes the human stomach and duodenum. In some cases it may cause stomach cancer[1][2] and MALT lymphoma[3]. Animal models have demonstrated Koch's third and fourth postulates for the role of Helicobacter pylori in the causation of stomach cancer.[4]

[edit] Suspected to cause cancer

Mycoplasma has been implicated in the formation of cancer.[5] Specific reports include:

* Mycoplasma can “induce malignant transformation of host mammalian cells” by means of "aberrant expression of oncogenes and tumor repressors"[6].
* A "Mycoplasma hyorhinis-encoded protein known as p37…..(could) infect humans and may facilitate tumor invasiveness" [7].
* A “significantly high existence of Mycoplasma sp. DNA" has been reported "in the tissues of patients with conventional (renal cell carcinoma)" as opposed to normal controls.[8]
* "Mycoplasma infection can be detected in many tumor tissues; continuous infection of mycoplasma can lead to transformation of mammalian cells, up-regulating expression of oncogenes, and some biologic changes of tumor cells, suggesting association of Mycoplasma infection with tumorigenesis"[9]

A number of other bacteria have associations with cancer, although their possible role in carcinogenesis is unclear. Salmonella typhi is associated with gallbladder cancer, Streptococcus bovis is associated with colorectal cancer and Chlamydia pneumoniae with lung cancer.[10]"


http://www.pubmedcentral.nih.gov/art...?artid=1479838

Article posted on Pubmed from the Journal of Transitional Medicine suggests these bacteria cause these cancers:

Salmonella typhi and gallbladder cancer
Chlamydophila pneumoniae and lung cancer
Streptococcus bovis and colorectal cancer
E. coli, crohn's disease and colon cancer

http://ezinearticles.com/?Do-Bacteri...cer?&id=641484

Another interesting article on this subject.

[Niels]

Originally Posted by tcmgpt13

I believe there may be more than one bacteria involved in causing cancer, and that this may be why Cantwell calls it a cancer microbe:

The Powell patent I posed above contains this about the different microbes claimed causing cancer and autoimmune disease... similar to the ones you posted in your response.

"especially Chlamydia pneumoniae (Cpn), Mycoplasma pneumoniae (Mpn), Helicobacter pylori (Hpi), and/or fungal infections."

Just for the record -- this morgie has: borrelia+, CpN+, MpN+, HHV6+, EBV+ (very high titer)
all of which together give you a completely pathetic immune sytem that cannot fight off an kind of skin infection.

[tcmgpt13]

Since discussion about the connection between cancer and Morgellons has been recently brought up on some threads, I thought I would bring back this thread which discusses a controversial subject, the cancer microbe and Russell bodies. I found another article, written by Alan Cantwell, on rense.com and felt it would add to the discussion already on this thread. An interview of Cantwell is in the first post. Too bad Cantwell was no longer at Kaiser when the CDC did the Morgellons study:

The Forgotten Clue To The Bacterial Cause Of Cancer

Perhaps the cancer microbe is the missing key behind Morgellons, the one commonality all share. Even some diseased wild life washed ashore (sea lions, dolphins, seals) are displaying signs of cancer (lesions, tumors). Cancer would lower the ability of the immune system to fight off other illnesses and parasites.

[Robin]

HI TCM,
I am amazed after reading this! WOW! this is so crazy they are not trained to even think of the possibility of parasitic diseases! all these years of it staring them in the face and these frickin dummies keep they're eyes closed and wallets open! Thanks for bringing this one back its the first time i've seen it.i'm still thinking about how incredible this is and how one arrogant dr's opinion can change peoples minds so quickly!
xo
Robin